Utilizing model nanostructured porous inorganic compounds such as silica to beneficially confine "bio"-relevant molecules and demonstrate their potential in therapeutics by Bhattacharyya, Aninda J & Mandal, Soumit S
Journal of the Indian Institute of Science  VOL 91:4  Oct.–Dec. 2011  journal.library.iisc.ernet.in 485
Reviews
Solid State and 
Structural Chemistry 
Unit, Indian Institute 
of Science, Bangalore 
560012, India
*aninda_jb@sscu.iisc.ernet.in
1. Introduction
With the emerging trends and recent advances 
in nanotechnology,1–3 it has become increasingly 
possible to employ nanomaterials to address 
various shortcomings typically associated with 
conventional methods used for tackling different 
issues or problems in biotechnology. For example, 
by using nanoscale drug delivery vehicles, the 
pharmacological properties (e.g., solubility and 
circulating half-life) of various drugs can be 
dramatically improved leading ultimately to the 
discovery of optimally safe and effective drugs. 
Current nanotechnology-based therapeutic 
products have been mainly validated through 
the improved effectiveness of approved drugs. 
Following initial successes, many novel strategies, 
such as devices based on nanotechnology 
relevant to different areas of biotechnology have 
been conceived and are in advanced stages of 
development. Some of these areas are in vitro 
diagnostics, in vivo imaging, therapy techniques, 
biomaterials and tissue engineering. In this review, 
we discuss the applications of nanotechnology 
focusing specifically on controlled drug delivery 
and biomolecular sensing. Both these issues 
are discussed in detail utilizing model porous 
nanostructured inorganic materials such as 
silica (SiO
2
). It is supposed that these model 
studies would effectively lead to the design of 
better inorganic and hybrid multifunctional 
nanostructured host materials for diverse 
biotechnological applications.
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2. Drug Delivery
Research breakthroughs in designing pharmaceu-
tical drugs for different diseases have greatly aided 
in advancing the knowledge of the physicochemical 
properties of drug molecules and the mechanisms 
of cellular uptake. This has led to numerous 
effective therapeutic strategies. In the treatment 
of cancer by chemotherapy, for example, prevalent 
therapies primarily employ cytotoxic drugs. 
These drugs when administered via conventional 
methods have limited utility and adverse side 
effects. To overcome this hurdle, a widely pursued 
strategy is to design a drug delivery system (DDS) 
that can transport an optimised dosage of drugs 
to the targeted cells and tissues. The success of 
this approach depends largely upon the ability 
to synthesize a biocompatible vehicle that allows 
high amounts of drug loading and prevents any 
premature drug release prior to reaching the target. 
A DDS in general should possess the following 
characteristic properties:
 • biocompatibility and biodegradability
 • high loading/encapsulation of desired drug 
molecules without any significant structural 
or morphological changes
 • minimum premature release
 • controlled release rate so as to obtain 
concentrations within the permissible 
pharmaceutical window of the drug
Though several biodegradable materials have 
been tried as drug carriers. However, every drug 
carrier exhibits some shortcomings. However, since 
the advent of biological nanostructures such as 
liposomes4 as carriers of proteins and drugs for the 
treatment of diseases, nanotechnology has made 
a significant impact on the development of drug 
delivery systems. They were considered “smart” 
drug delivery systems as they could be tuned 
to release pharmaceutical drugs in a controlled 
manner under physiological conditions in an 
aqueous solution. The release takes place following 
the structural degradation of the carrier which is 
triggered by various chemical factors, such as pH. 
Based on this principle of drug carrier degradation, 
a variety of nanomaterials, mainly organic 
(polymeric), have been utilised as delivery vehicles 
to serve various therapeutic modalities. So far, 
there have been over a few dozen nanotechnology-
based therapeutic products approved by the Food 
and Drug Administration (FDA) of the United 
States of America for clinical use and several are 
in clinical trials. Compared to conventional drug 
delivery, nanotechnology based systems provide 
a number of advantages. In particular, they can 
enhance therapeutic activity by prolonging drug 
half-life, improving the solubility of hydrophobic 
drugs, reducing potential immunogenicity and 
releasing drugs in a sustained manner. The drug 
can also be released in a controlled manner under 
an external stimulus. In this way, the toxic side 
effects of drugs can be reduced as well as their 
administration. In addition, nanoscale particles 
can passively accumulate in specific tissues e.g., 
tumors, due to enhanced permeability and 
retention (EPR) properties.5 Beyond displaying 
clinical efficiency, nanotechnology has also been 
utilized to bring about new therapies and develop 
next generation nanosystems for “smart” drug 
delivery. In the following sections, we discuss 
various modes of drug delivery utilizing inorganic 
nanostructured drug vehicles (section #3). We also 
discuss the implications of confinement at the 
nanoscale on the structure and function of ‘bio”-
relevant molecules such as drugs, proteins and 
enzymes (section #4).
3.  Porous Nanostructured Inorganic 
Materials as Hosts for the Controlled 
Delivery of Various “Bio”-Relevant 
Molecules
As discussed previously, for the complete 
effectiveness of a drug, a suitable delivery vehicle 
is always desirable. Polymer-based materials, 
although biodegradable and biocompatible, are 
unstable and also lack the desired circulation 
times within the blood. Generally, polymer-based 
drug delivery vehicles undergo rapid chemical 
degradation (such as hydrolysis) upon dispersion 
in water and thus display burst release kinetics 
of the encapsulated compound. Polymeric 
systems generally require usage of organic 
solvents for drug loading and these can trigger 
undesirable modifications of the host structure 
and/or function of the encapsulated molecules 
such as protein denaturation and aggregation. 
Additionally, drug loading amounts are low in 
polymer DDS. There are several excellent reviews 
on polymer-based drug delivery vehicles2 and the 
reader may refer to them for more details. The 
discovery of highly-ordered mesoporous silica 
materials by scientists at the Mobil Corporation 
in 1992 (Mobil Crystalline Materials, abbreviated 
as MCM), was quickly recognized as a major 
breakthrough that could lead to a variety of 
important applications.6,7 The implications 
of mesoporous materials in the field of drug/
enzyme delivery as well as other biotechnological 
applications also came into the limelight 
(figure 1). Mesoporous materials have a uniformly 
connected pore network with the pore diameter 
Mesoporous materials: Porous 
materials with interconnected 
pores (size range: (2-50) nm) 
arranged in a definite 
geometrical arrangement. 
The high pore surface area is 
particularly useful for a wide 
variety of applications.
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ranging from 2–50 nm, and possess high surface 
areas 1500 m2/g (pore volumes ∼1 cm3 g−1). This 
property, along with high chemical and thermal 
stability, and easy surface functionalization, 
makes mesoporous silica an ideal candidate 
for supporting adsorption, catalysis, chemical 
separations and biotechnology devices.8–11 The 
chemical stability of silica or, in general, inorganic 
compounds, prevents the premature release of 
drug molecules or any unnecessary interaction 
of the guest molecules (inside the host) with the 
analytes in solution. Significant research efforts 
have been directed to achieving control over the 
pore size and morphology of mesoporous silica. 
This has led to the development of new silica 
materials such as Santa Barbara Amorphous 
(abbreviated as SBA),12 Michigan State University 
(abbreviated as MSU)13 and folded sheet 
mesoporous (abbreviated as FSM) materials14 
with characteristic pore morphologies. The 
discovery of mesoporous silica also triggered 
the development of various inorganic, organic 
and even inorganic/organic hybrid materials 
with mesoporous structures. At SSCU, IISc, we 
performed systematic studies on the influence of 
the host nanostructure morphology and surface 
chemistry on drug release (figures 2–6). Based 
on our studies using model DDS based on silica 
(SiO
2
), titania (TiO
2
), and alumina (Al
2
O
3
) the 
drug release kinetics has been observed to depend 
strongly and also on several parameters of the 
nanostructured host such as pore size, volume, 
configuration as well as on the surface chemistry 
and dimension of the host. Mesoporous systems 
are not the only inorganic structures which 
have biotechnological applications. Other 
nanostructured materials such as nanospheres, 
nanotubes (for e.g., figure 6) and hierarchical 
structures have also received considerable 
attention. Even in such cases the release kinetics 
has also been observed to depend strongly on the 
host morphology and chemistry.
Figure 1: Schematic diagram showing drug release from inorganic mesoporous materials such as alumina (Al
2
O
3
) and MCM-silica 
(SiO
2
). The drug loading and release kinetics can be effectively controlled by the tuning of pore characteristics and surface chemistry. 
The decoration of the pore surface with two different chemical functionalities enables the mesoporous host (also known as “Janus” 
particles) to deliver two different drugs.
Nanostructured materials: 
General terminology used to 
refer to nanomaterials varying 
in geometrical dimensions, 
shapes and internal 
morphology. It encompasses  
both inorganic and organic 
materials.
Janus particles: The term is 
used to describe spherical 
particles with one hemisphere 
hydrophilic and the other 
being hydrophobic.
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3.1  Mesoporous inorganic nanoparticles as drug 
carriers
The drug delivery applications take advantage 
of the high surface area (≥1000 m2 g−1) and pore 
volume (≥1 cm3 g−1) of mesoporous materials 
such as MCM silica. Guest drug molecules can 
be suitably adsorbed on to the mesopore surface. 
The drug loading and release are governed by pore 
morphology and surface chemistry (figures 2 and 
3). The group of Vallet Regi at Madrid were the first 
to demonstrate the utility of mesoporous oxides 
such as MCM-41 silica for drug delivery. Several 
reports15 from the Madrid group demonstrated 
the importance of pore morphology and their 
configurations on drug delivery. Victor Lin’s group 
at Iowa State University has also contributed 
considerably towards understanding the effect of 
the pore and particle morphology of mesoporous 
silica.16 A room-temperature ionic liquid (RTIL) 
template mesoporous silica nanoparticle (MSN) 
system, abbreviated as RTIL-MSN, with various 
particle morphologies including spheres, ellipsoids, 
rods and tubes for the controlled release of 
antimicrobial agents, was developed. By changing 
the RTIL template, the pore morphologies could be 
tuned from the MCM-41-type hexagonal mesopores 
to the rotational Moiré-type helical channels and to 
wormhole-like porous structures. It was observed 
that the spherical/hexagonal mesopore RTIL-MSN 
exhibited superior (1000-fold) antibacterial activity 
compared to the tubular/wormhole RTIL-MSN. The 
results were accounted for by the fact that the rate 
of release via diffusion from the parallel hexagonal 
channels was faster than that from the disordered 
wormhole pores. Thus, the role of texture and 
structure host matrices was clearly demonstrated. 
In addition, Lin’s group has also studied the effect 
of pore enlargement and chemical functionalization 
of mesoporous silica on the target-specific delivery 
of proteins into plant cells17,18
Hybrid silica-based mesoporous materials can 
also be employed to serve specific clinical needs. 
In the simplified sense, hybrid silica particles can 
be obtained by modifying the mesoporous silica 
pore surface with covalent attachments of organic 
functional groups.19 The organic functional 
groups can be used to anchor several types of 
drugs. The attachment of the drug to the matrix is 
either through electrostatic attractive interactions, 
hydrophilic–hydrophobic forces or electronic 
interactions.18–20 Vallet-Regi and his co-workers 
observed that the loading of L-tryptophan was 
greatly enhanced when the surface of SBA-15 
was modified using quaternary amines with 
different alkyl lengths (methyl and octadecyl).23 
The importance of surface chemistry is also duly 
Figure 3: Kinetics of ibuprofen (IBU) release in simulated body fluid 
(SBF, pH-7.4) from alumina (Al
2
O
3
): X samples (X: acidic (A), basic (B)). 
Release kinetics observed via monitoring characteristic peak at 264 nm 
of IBU by UV-vis spectroscopy. The plot clearly shows correlation between 
density of surface silanol groups and drug loading (not shown here) and release 
kinetics. Higher [-OH] density (i.e. higher acidity) results in stronger drug host 
interaction and hence slower release of IBU.24
Figure 2: Release kinetics of ibuprofen (IBU) from alumina (Al
2
O
3
)–X 
(X: -OH, -CH
3
,-NH
2
,-DN: 2,3-dihydroxynaphthalene) into simulated body fluid 
(SBF, pH = 7.4) at 25°C.25 Release kinetics observed via monitoring the 
characteristic peak at 264 nm of IBU by UV-vis spectroscopy. The plot 
clearly shows a correlation between release kinetics and the hydrophobicity/
hydrophilicity of the oxide surface. Hydrophobic surfaces showed faster release 
of IBU in aqueous simulated body fluid compared to hydrophilic oxide surfaces.
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demonstrated in refs.9–11 where MCM-41 was 
functionalised with an aminopropyl group. The 
amino group is protonated during the loading 
process either by its reaction with the acid group 
of the drug in a non-polar aprotic solvent or by 
loading the drug at a pH below the pK
a
 value for 
primary amines (9–11). The release takes place 
at a physiological pH of 7.4, at which value the 
amino groups remain protonated. It was found 
that the MCM-41 (pore diameter: 3.8 nm; surface 
area: 1157 m2/g) and SBA-15 (pore diameter: 
9 nm; surface area: 719 m2/g) surfaces when 
modified with aminopropyl groups, resulted in 
an increase of alendronate by almost 3 times 
compared to unmodified MCM-41.21 Further, a 
remarkable decrease of the initial burst effect was 
noticed. Almost 55% of the alendronate loaded 
into the unmodified SBA-15 was released in the 
medium during the first 24 h of assay, while the 
amino-functionalised SBA-15 showed a release of 
only 11%. The different release kinetics between 
unmodified and amino modified SBA-15 proves 
beyond doubt the importance of surface chemistry 
on drug loading and release. The drug release rate 
can be retarded/accelerated by appropriately tuning 
the hydrophobicity/hydrophilicity of the pore 
surface. The presence of hydrophobic functional 
groups does not allow the aqueous solution inside 
the pores24 thus slowing down the drug release. The 
release of macrolide antibiotic erythromycin from 
SBA-15 was modulated by organically modifying 
the surface with C
8
 (octyltrimethoxysilane) and 
C
18
 (octadecyltrimethoxysilane) hydrocarbon 
chains respectively. Functionalization resulted in a 
decrease of surface area and effective pore size of 
mesoporous matrices which led to a decrease in the 
amount of drug loading in functionalized SBA-15 
compared to bare SBA-15. Functionalization also 
led to a reduction in the wetting ability of the 
SBA-15 surface by aqueous solution. This resulted 
in a marked decrease in drug release kinetics 
from functionalised samples compared to bare 
SBA-15. The effect of surface hydrophobicity/
hydrophilicity on drug release rates has also been 
systematically studied by Kapoor et al27 (figure 2). 
The Decoration of mesoporous alumina-neutral 
(abbreviated Al
2
O
3
-N) with various types of 
silane (such as 3-aminotrimethoxysilane-APTMS, 
methylmethoxysilane-MTMS) and other groups 
(such as 2, 3-dihydroxynaphthalene-DN) leads 
to different release kinetics. The hydrophobic 
functionalization of the Al
2
O
3
 surface resulted 
in a low degree of drug loading (∼20%) but 
faster release rates (85% in 5 hours). The 
functionalization of the Al
2
O
3
-N surface with 
hydrophilic groups on the other hand showed 
higher drug loading (21–45%) but release rates 
comparatively slow (12–40%). The drug release 
from mesoporous Al
2
O
3
 was found to be diffusion 
controlled (∝ time0.5). Thus, we can conclude 
that both the chemical character of the various 
functional groups lining the alumina surface and 
the pore characteristics (including the wide pore 
size distribution of (2–8) nm) played a key role in 
altering the nature of drug release kinetics.
Das et al ref26 presented a systematic study 
of drug loading and release kinetics from 
commercially available mesoporous alumina 
(Al
2
O
3
) nanoparticles with varying densities of 
surface silanol functional groups (figure 3). The 
density of the silanol groups determined the 
acidity/basicity of the surface. Acidic-Al
2
O
3
 (i.e. 
Al
2
O
3
 with the highest amounts of OH groups) 
exhibited the highest drug loading capacity of 26% 
while basic-Al
2
O
3
 (i.e. Al
2
O
3
 with low amounts of 
OH groups) was the lowest with 22%. Through 
systematic variation in several parameters, it was 
found that the release of IBU from basic-Al
2
O
3
 
was significantly faster compared to acidic-Al
2
O 
3
. 
This is accounted for by the stronger interaction 
between the drug and its mesoporous host in the 
case of the acidic-Al
2
O
3
 sample compared to the 
basic-Al
2
O
3
 sample. The pH of the release medium 
and the ratio of concentration of Al
2
O
3
 : IBU also 
influenced the release kinetics. Further, IBU release 
kinetics as a function of external stimuli (such as 
pH) was observed to be strongly dependent on 
oxide surface acidity.
Mesoporous materials can also be suitably 
designed to carry multiple payloads. “Janus” 
mesoporous nanoparticles (figure 1) which have 
two different surface functional groups can be 
prospective hosts for the controlled delivery of two 
different kinds of drugs. The concentration of the 
surface chemical groups controls both the loading 
as well as the release kinetics of the individual drug. 
The other possibility for hosting more than one 
drug can be achieved via the usage of dendrimers. 
Dendrimers are highly branched monodispersed 
macromolecules possessing a large number of 
functionalities. Dendrimers have many bio-medical 
applications, for example, as contrast agents in 
magnetic resonance imaging, gene transfection 
therapies, and in drug delivery.25
The application of mesoporous materials 
has been recently extended to enzyme-inhibitor 
delivery28 (figure 4). Studies were carried out 
using a model protein Chick retinal tyrosine 
phosphotase-2 (CRYP-2), a protein that is identical 
to the human glomerular epithelial protein-1, and 
present in hepatic carcinoma. The inhibition of 
CRYP-2 was demonstrated through the delivery 
RTIL: Ionic liquids are 
salts in the liquid state. 
Room temperature ionic 
liquid abbreviated as RTIL 
are mainly organic salts 
containing of bulky and 
asymmetric organic cations 
such as alkyl-imidazolium/
pyridinium with anions 
such as halides existing in 
the liquid state at room 
temperature.
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of p-nitrocatechol sulfate (pNCS) from bare and 
amine-functionalized mesoporous silica (MCM-48) 
and mesoporous alumina (Al
2
O
3
). MCM-48 
functionalised with an amine moiety exhibited 
the best release of pNCS and hence inhibition of 
CRYP-2 with a maximum speed of reaction (v
max
 = 
160 ± 10 µmol/mnt/mg) and an inhibition 
constant K
i
 = 85.0 ± 5.0 µmol. This value was 
close proximity to the values obtained for protein 
tyrosine phosphatase inhibited via conventional 
methods. This strongly supports our view of the 
employment of inorganic nanostructured media 
for the inhibition of enzymatic activity.
3.2  Drug release using silica nanotubes (SNT) 
and the effect of external stimuli
The use of porous nanostructured materials of 
different configurations and dimensions for drug 
delivery has also been a subject of considerable 
interest. Kapoor et al used silica nanotubes to 
demonstrate the controlled drug delivery of 
Ibuprofen (IBU)29 (figures 5 and 6). SNTs were 
synthesised using the standard sol-gel template 
method. The diameter of the SNTs could be 
suitably tailored from (50–200) nm depending on 
the guest molecule size. The effects of chemical 
functionalization as well as external stimuli on 
drug release kinetics were also discussed. The 
surface modification and drug loading were carried 
out using the procedures discussed previously. 
The SNTs under physiological conditions 
exhibited a very poor rate of IBU release (20% 
in 30 h). This was accounted for by the presence 
of morphological heterogeneities (e.g., junctions, 
bends) which posed steric hindranse for the 
fast diffusion of the solvated drug out of the 
nanotube. The drug release rate was slow when 
compared to standard mesoporous materials 
such as MCM-48 (∼90% release within 30 h). The 
IBU kinetics change significantly as a result of 
the functionalization of the SNT surface with 2, 
3-dihydrox-ynaphthalene (DN). The IBU release 
kinetics from SNT-2, 3-dihydrox-ynaphthalene 
(abbreviated SNT-DN) was intermediate to 
that of SNT and MCM-48. After ∼13 h the IBU 
release from SNT-DN became higher than that for 
MCM-48. Nearly 95% of IBU was released from 
SNT-DN in 24 h compared to 87% for MCM-48 
and 20% for SNT. The slow initial release in the case 
of the SNT-DN was attributed to the dominance 
of attractive interaction (such as π- π) between the 
surface naphthalene group and IBU over that of 
the solvation of IBU (i.e. the COOH group) by the 
SBF. The faster release of IBU at longer time scales 
from SNT-DN compared to that from MCM-48 
(average pore size ∼2.5 nm) was attributed to the 
difference in morphology of the nanostructured 
materials. The drug release rate of SNT could 
also be drastically altered using external stimuli 
in the form of ultrasound30 impulses. Ultrasound 
impulses have been used previously in the case 
of insulin release from the MCM-41/-48 matrix 
modified with PDMS. Other forms of external 
stimuli such as electrical field have also been used 
to release insulin from polymer matrix composite 
(PEOx and PMMA).31 An optimized ultrasound 
protocol of high frequency, short duration 
impulses and short waiting times leads to a linear 
rate of ibuprofen release from SNT. A few tens 
of percentage enhancements were obtained over 
approximately 100 min in comparison to bare 
SNT which exhibited a mere 20% release yield 
over 30 h (figure 6). The external stimuli created 
percolation pathways (via the removal of SNT 
heterogeneities) for the aqueous SBF to leach out 
IBU from the pores of the nanotube. This led to 
improved pharmacokinetics of IBU.
3.3 Gated drug delivery systems
As discussed earlier, an important attribute of DDS 
is to release a drug at a controlled rate at a specific 
site of interest. Lin et al developed a series of 
stimuli-responsive mesoporous silica nanoparticle 
(MSN)-based controlled release systems. They 
demonstrated a gated MSN system where the 
drug loaded mesoporous material was capped by 
mercaptoacetic acid coated CdS nanocrystals32 
Figure 4: Paranitrocathecol sulfate (abbreviated pNCS) inhibitor release profiles 
into 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) at 25°C from 
Al
2
O
3
/Al
2
O
3
-NH
2
 and MCM-48/MCM-48-NH
2
.26
SBF: Simulated body fluid 
abbreviated as SBF is 
laboratory prototype having 
inorganic ion concentrations 
similar to those of human 
extracellular fluid.
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through a chemically cleavable disulfide linkage. 
This was done to prevent premature drug release. 
The drug was released through the exposure of 
the capped MSNs to chemical stimulation such 
as dithiothreitol (DTT) and mercaptoethanol 
(ME) that cleaves the disulfide linker. Other 
than chemically stimulated release, Tanaka 
and his co-workers demonstrated a reversible 
photocontrolled release system in an organic solvent 
using coumarin-modified mesoporous silica.34 The 
release of the steroid cholestane stored within the 
mesopores was prevented by the coumarin that 
was covalently attached to the MCM-41 pore walls 
through a photodimerization reaction that yielded 
cyclobutane. The release was triggered by exposure 
to a UV light wavelength of ∼250 nm to cleave 
the cyclobutane ring of the coumarin dimmer.34 
Zink, Stoddart, and their co-workers developed 
an electrochemically-controlled delivery system 
based on a pseudorotaxane cap that could undergo 
conformational changes triggered by redox 
chemistry.35 The mesopores were loaded with 
Ir(ppy)3 (ppy: 2,2′ -phenylpyridyl), a fluorescent 
molecule. The opening of the gate was stimulated 
by the addition of an external reducing agent 
which caused the pseudorotaxane to disassemble.
Drug release under the application a of mag netic 
field has also been demonstrated. Lin et al designed 
Figure 5: A schematic diagram showing drug release from silica nanotubes (SNTs) under 
ultrasound impulses and from surface functionalized SNTs. The external stimuli and surface 
chemical functionalization were required to accelerate the release yields of bare SNT.
Figure 6: Ibuprofen (IBU) release from silica nanotubes (SNT) with 
an ultrasound impulse protocol of 0.5 min duration impulses and 2 min 
rest time. The application of ultrasound results in the enhancement of 
IBU release by a few tens of percentage over 100 mins compared to a 
total release of only 20% over nearly 30 h from bare SNT.
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a MSN material capped with superparamagnetic 
iron oxide (Fe
3
O
4
) nanoparticles.36 The device 
consisted of rod-shaped MSNs functionalized with 
3-(propyl disulfanyl) propionic acid (average particle 
size of 200 nm × 80 nm and pore size ∼3 nm) with 
the pores bound with 3-aminopropyltriethoxysilyl-
functionalized superparamagnetic iron oxide 
(APTS-Fe
3
O
4
) nanoparticles. The response to 
the magnetic impulse was verified by placing the 
sample between bar magnets. The drug release was 
triggered by dithiothreitol (DTT).
Another very interesting approach is the 
concept of dual drug delivery i.e. the simultaneous 
release of two drugs in response to a stimulus. Lin 
et al a developed a boronic acid-functionalized 
mesoporous silica nanoparticle-based drug 
delivery system for a glucose-responsive controlled 
release of both insulin and cyclic adenosine 
monophosphate (cAMP).37 The stimulus for 
the release was achieved using saccharides. The 
gluconic acid modified insulin was labelled with 
a Fluorescein isothiocyanate and this served as the 
gatekeeper altering the drug release. The decrease 
in the amount of labelled insulin triggered the 
release of cAMP. The triggering effect of other 
saccharides such as fructose, and glucose on the 
release rates were also studied.
The various studies discussed above have 
established beyond doubt that drug loading 
and release from mesoporous and tubular 
structures can be modulated by controlling the 
host morphology and surface chemistry as well 
as the response to external stimuli. It was also 
shown that numerous pore-capping agents can be 
incorporated to encapsulate drugs and chemicals 
in the mesopores of inorganic hosts. Porous 
inorganic and hybrid structures can suitably 
adapt to participate in various biological processes 
including intracellular functions. A suitable 
selection of materials and processes should be 
developed for all such applications. Based on the 
rapid advances in the synthesis and processing 
of inorganic materials, one foresees applications 
of biocompatible and biodegradable inorganic 
nanostructures in the not too distant future.
4.  Effects of Confinement Inside Inorganic 
Host Materials on the Structure and 
Function of Bio-Molecules and their 
Implications in Drug Delivery and 
Sensing
Conditions different from normal physiological 
temperature and pH often lead to enzyme protein 
denaturation and hence, loss of reactivity and 
selectivity. Moreover, the use of free enzymes 
has several processing difficulties with regard 
to re-usage, contamination and separation. 
One approach to resolve these difficulties is 
to immobilize enzymes on solid surfaces. The 
immobilization of proteins from a solution onto 
solid surfaces of complementary charge has for 
long attracted much attention due to its potential 
application in several areas.38–40 The adsorption 
of proteins over controlled porous glass (CPG) 
and sol-gel derived nanocomposite materials for 
possible applications such as biosensors and other 
biological applications has been reviewed by several 
research groups.41–45 The major disadvantage of 
CPG materials for adsorption studies is their high 
cost and lower surface area of interaction (pore size 
∼(30–200) nm).46 Enzyme encapsulation inside 
silica gels was also attempted.47 However, due to 
small and non-uniform pore size distribution 
and the lack of a connected pore network as in 
mesoporous materials, the enzyme usually showed 
less activity than its free counterparts. However, 
following the discovery of mesoporous silica 
materials with controlled pore architecture there 
has been a vast improvement in enzyme stability 
especially in extreme environmental conditions, 
catalytic activity and products specificity. The use of 
porous materials in bioadsorption and biocatalysis 
has been extensively reviewed by Hartmann48 and 
Zhao.49 These reviews provide a comprehensive 
account of the application of mesoporous materials 
to immobilize biological molecules of varying 
sizes: amino acid to proteins. Other than these 
mesoporous materials, nanostructured materials 
in other dimensions (1-D; 2-D) have also been 
used for bio-molecular encapsulation.
4.1  Mesoporous silica-based materials 
for bio-molecule encapsulation
Mesoporous silica, in addition to possessing a well 
defined pore structure, also has a high density 
of surface silanol groups. These can be suitably 
modified with a wide range of organic functional 
groups for immobilizing biomolecules. The 
immobilization of globular enzymes, cytochrome 
c (bovine heart), papain (papaya latex) and trypsin 
(bovine pancreas) was carried out in mesoporous 
molecular sieves such as MCM-41.50 The efficiency 
of enzyme immobilization was found to be pH 
dependent and it varied for different enzymes. 
The silanation of pores after trypsin adsorption 
eliminated the leaching of the enzyme into 
a solution at high pH. It was also found that 
entrapped trypsin hydrolysed N-α-benzoyl-DL-
arginine-4-nitroanilide (BAPNA) and its stability 
was also enhanced by its physical entrapment 
in MCM-41. Similiar observations were also 
reported with SBA-15.51 Thiol, chloride, amine, 
Biosensors: A device for 
detection of biological 
analytes generally, in solution. 
Electrochemical biosensors 
give an electrical signal in 
response to chemical reaction 
between the analyte and a bio-
relevant molecule in the bio-
recognition layer (working 
electrode-WE) of the sensor. 
For accurate quantification 
of the electrical response, two 
other electrodes are necessary 
viz.: reference electrode (RE); 
counter electrode (CE).
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carboxylic acid and phenylsiloxane incorporated 
SBA-15 were used to immobilise trypsin and 
were more retention of the enzyme molecules 
was more than unfunctionalized SBA-15. The 
resulting encapsulated enzyme was also found to 
be an active and stable catalyst for the hydrolysis 
of BAPNA. Additionally, trypsin supported on 
thiol-functionalised SBA-15 was shown to be 
recyclable.
In addition to pore size, the surface charges 
of the protein and of the mesoporous material 
have to be complementary.52 Pepsin at pH 6.5, 
for example, is negatively charged and does not 
adsorb onto cyan-modified silicate, whereas 
subtilsin, which is of a similar size and bears an 
overall positive charge, is adsorbed. Using Raman 
spectroscopy, cytochrome c was observed to occur 
in both high spin and low spin states. In solution, 
however the protein is predominantly in the low 
spin state. The presence of the high spin state may 
account for the enhanced per oxidative activity of 
the adsorbed protein.
Enzyme immobilization is also influenced 
by the pore structure of the host. This was 
demonstrated in the case of the immobilization 
of cytochrome c into MCM-48, SBA-15 and the 
layered transition metal oxide Nb-TMS4.53 Greater 
protein loading was observed for the three-
dimensional MCM-48 which had the highest 
surface area compared to the one-dimensional 
hexagonal SBA-15 and two-dimensional layered 
Nb-TMS4. Cyclic voltammetry studies showed that 
the entrapped cytochrome c retained its activity 
upon encapsulation. Thr beneficial influence of 
encapsulation on protein function was reported 
by Vinu et al for cytochrome c54 and by Takahashi 
et al for horseradish peroxidase (HRP).55
Eggers and Valentine carried out a circular 
dichroism study with sol-gel encapsulated proteins 
to examine the effects of macromolecular crowding 
and hydration effects on protein stability.56 It was 
concluded that the stability of the proteins in 
the confined environment was governed by two 
important factors i.e. excluded volume effects 
and water structure changes in a confined space. 
Lysozyme, α-lactalbumin and metmyoglobin 
retained their native solution structures following 
sol-gel encapsulation, but apomyoglobin was found 
to be largely unfolded within the silica matrix 
under control buffer conditions. Using elastic 
neutron scattering, Schirò et al studied the effect 
of hydration on the dynamics of metmyoglobin 
encapsulated in a sol-gel matrix.57 It was observed 
that the level of hydration in the porous silica matrix 
strongly affects the mean square displacements of 
protons in the confined protein, but not in the 
bulk protein. Confinement also has adverse effects 
on the protein structure as reported by Sorin and 
Pande.58 Through molecular dynamics simulation, 
it was shown that the confinement of proteins 
inside a carbon nanotube denatures protein 
helices. It was found that both surface chemistry 
and topography play key roles in determining the 
structure of the bound proteins.59,60
Kapoor et al recently investigated the influence 
of confinement on the structure of native 
Hemoglobin, (abbreviated Hb) and its effect on 
the ligand binding activity of Hb (figures 7–9). The 
consequence of confinement inside SNTs on protein 
structure was further discussed via thermal stability 
and electrochemical activity studies.61 The reversible 
binding of pyridine and its derivatives indicated the 
absence of any adverse effects on the structure and 
function of Hb as a result of confinement (figure 8). 
Additionally, the melting /thermal denaturation 
temperature of the confined Hb was enhanced by 
approximately 4°C as compared with that of free 
Hb in solution (figure 9). Similar thermal stability 
as a result of confinement was also observed in the 
case of lysozyme. Contrary to some reports based 
on carbon nanotubes, confinement inside silica 
nanotubes did not have any adverse effect on the 
protein structure and function. Rather, it had more 
beneficial effects when compared to the protein in 
the free state. The optimized morphology of the 
nanostructured host is not expected to impose any 
restriction on the favourable protein conformations 
Figure 7: A schematic diagram showing the effects of confinement 
investigated using electrochemical techniques (such as cyclic voltammetry) 
circular dichroism spectroscopy, x-ray diffraction (not shown here).
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requisite for primary protein activities such as 
ligand binding. Confinement may reduce protein 
dynamics but this may be a blessing in disguise as 
it would allow the protein to remain in favourable 
conformations for longer periods of time.
On the basic research front, confinement is an 
interesting and formidable statistical mechanics 
problem. Several important issues such as 
intermolecular interaction, host-guest interactions, 
the role of water in confined space all have to be 
taken into consideration for a comprehensive 
understanding of the confinement phenomenon. 
Though not discussed explicitly (in section #3), 
confinement also plays a very important role in 
drug delivery. The nanostructured host plays 
a crucial role in determining the molecular 
conformation during its residence inside the host 
as well as it release from the host. A recent work 
by Mandal et al62 reveals the strong dependence 
of ibuprofen conformation (S or R form) on the 
morphology of mesoporous titania and titania 
nanotubes. The host morphology also determined 
the drug conformation when released into 
the simulated body fluid buffer under normal 
physiological conditions.
5. Conclusion and Future Perspectives
We have convincingly shown here that the 
encapsulation of “bio”-relevant molecules 
in specially designed nanostructures opens 
several possibilities of improving the molecular 
stability, activity and function desired for various 
biotechnological applications. Nanostructured 
materials exhibit great versatility and can 
also be utilized to control regioselectivity, 
enantioselectivity or even reverse the properties 
of the native enzyme. The design of a suitable 
porous host material and formulating a requisite 
protocol for the encapsulation of “bio”-relevant 
molecules is a challenging task. However, with 
the rapid strides made by nanotechnology, it is 
expected that such hurdles will be overcome with 
ease in the coming years. The immobilization of 
molecules inside a space of nanoscale dimensions 
provides several interesting problems of theoretical 
interest. Confinement at the nanoscale presents a 
mesoscopic situation as it demands modelling 
of various phenomena using much fewer 
(<< Avogadro number, N
a
 ∼ 1024) molecules. We 
conclude that a sound theoretical understanding 
of various complex phenomena at the mesoscale is 
necessary for the design of better multifunctional 
inorganic materials. This will effectively lead to a 
predictable and beneficial confinement of a wide 
range of “bio”-relevant molecules for diverse 
biotechnological applications.
Figure 8: Cyclic voltammogram of (a) silica nanotubes (SNT) (b) native 
hemoglobin and hemoglobin confined inside SNTs. The SNT-Hb is immobilized 
on the glassy carbon electrode (GCE). This whole assembly is abbreviated as 
SNT-Hb/GCE. Scan rate and buffers were respectively 0.01 V s-1 and 0.1 M 
Phosphate buffered saline (PBS) buffer (pH-7.0). Inset: Transmission electron 
microscope (TEM) images of SNT (length ∼10 µm and diameter 50–200 nm) 
respectively.
Figure 9: Fraction of hemoglobin, Hb (f
u
) in the temperature range 25–85°C 
(heating rate 1°C/min) for free Hb in solution (0.1 M PBS, pH 7.0) and Hb 
confined inside SNTs, SNT-Hb obtained by monitoring the CD signal at 222 nm. 
Inset: Circular Dichroism spectra (CD) at 25°C for Hb and SNT-Hb in 0.1 M 
Phosphate buffered saline (PBS, pH-7.0).
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